Literature DB >> 455578

Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea.

W R McConnell, P Kari, D L Hill.   

Abstract

N-methyl-N-nitrosourea (MNU), N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea (methylCCNU), and N,N'-bis(2-chloroethyl)-N-nitrosourea (BCNU) were examined for their effect on glutathione (GSH) levels of various tissues of normal and L1210-leukemic mice. BCNU produced significant decreases in the GSH levels of livers of both groups, but caused no change in the GSH content of the L1210 tumor or in the lungs. The GSH content of the kidneys of L1210 tumor-bearing mice, however, was significantly decreased by BCNU at early time points. A small increase in the liver content of oxidized glutathione could not account for the decrease content of GSH. Methyl CCNU and MNU were without effect on any of the tissues examined. These data are consistent with our previous observation that BCNU is a substrate for GSH S-transferase, and suggest that a GSH-dependent process is an important pathway for the metabolism of BCNU.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455578     DOI: 10.1007/bf00258299

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  7 in total

1.  Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia.

Authors:  F M SCHABEL; T P JOHNSTON; G S McCALEB; J A MONTGOMERY; W R LASTER; H E SKIPPER
Journal:  Cancer Res       Date:  1963-06       Impact factor: 12.701

2.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

3.  Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea].

Authors:  H Frischer; T Ahmad
Journal:  J Lab Clin Med       Date:  1977-05

4.  Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

Authors:  D J Jollow; J R Mitchell; N Zampaglione; J R Gillette
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

5.  Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates.

Authors:  J R Babson; D J Reed
Journal:  Biochem Biophys Res Commun       Date:  1978-07-28       Impact factor: 3.575

6.  Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.

Authors:  S K Carter; J W Newman
Journal:  Cancer Chemother Rep 3       Date:  1968-12

7.  A toxicologic comparison of the potency and activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in mice and rats.

Authors:  G R Thompson; R E Larson
Journal:  Toxicol Appl Pharmacol       Date:  1972-03       Impact factor: 4.219

  7 in total
  1 in total

1.  Inhibition of glutathione synthesis augments lysis of murine tumor cells by sulfhydryl-reactive antineoplastics.

Authors:  B A Arrick; C F Nathan; Z A Cohn
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.